Egnyte

Webinar Details

On-Demand

Description:

A closer look at MIT Tech Review's Predictions for AI-Led Drug Development. In this roundtable, Jason Sparapani interviews IQVIA and Calithera discussing the latest findings on how AI is reshaping the way drugs are brought to market.

Speakers include:

Jason Sparapani
Content Manager, Insights
MIT Tech Review

Behrooz Najafi
CTO/CIO
Calithera

Nagaraja Srivatsan
Chief Digital Officer, R&D Technology Solutions
IQVIA

Duration of webinar:

25 minutes

On-Demand Webinar

UTM Campaign:

UTM Medium:

UTM Source:

UTM Term:

Person Source:

Consent Source:

ga.cid:

By registering I acknowledge I have read and understand Egnyte’s Privacy Policy

Number of Employees:

Country:

State:

Once a slow-paced, paper-first endeavor, drug research, is now a promising new frontier for AI-driven innovation, helping to bring life-saving drugs to market faster. It’s no small task. The estimated amount of health-care and life sciences data generated for each person in the world was 270GB as of 2020. That’s a huge volume of data to protect, keep compliant, and make sense of.

In this roundtable, Jason Sparapani will interview guests from IQVIA, Calithera, and Egnyte, to discuss the latest findings from MIT Tech Review and offer perspectives on how AI is reshaping the way drugs are brought to market.

Learn how AI accelerates drug development by:

Managing vast troves of data from research and development through clinical trials
Protecting valuable IP and reducing regulatory burdens
Connecting globally distributed teams and trial sites
Streamlining tasks such as tracking, auditing, and protecting personal health information

Check out MIT Tech Review’s full report.